tirzepatide march 19th FDA Announced Removal of from the Drug Shortage List Obesity drug seen as effective

If you miss multiple doses, your prescriber may want you to restart at a lower dose to avoid severe GI side effects

GLP-1 receptor agonists (GLP-1 RAs) are long-acting versions of this signal (liraglutide, semaglutide, dulaglutide, and the dual GIP/GLP-1 agent tirzepatide) developed to treat type 2 diabetes and, more recently, obesity

Keep Hydrated And Replace Electrolytes Sip water throughout the day, use oral rehydration solutions if you have vomiting or diarrhea, and include sodium and potassium-rich foods when appropriate

Customer service is great once I figured out to reach them

[CrossRef] Substance Identification Substance Name Tirzepatide CAS Registry Number 2023788-19-2 Drug Class Breast Feeding Milk, Human Hypoglycemic Agents Incretins Glucagon-Like Peptide-1 Agonists GLP-1 Agonists Disclaimer: Information presented in this database is not meant as a substitute for professional judgment

Patients on GLP-1 medications can lose lean body mass along with fat if protein intake is too low